Position in LLY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,653,139
+$757,494 QoQ
Shares Held
2,212
+7.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#2,243
of 4,605 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OARSMAN CAPITAL, INC. holds $20,990,952 across 10 Drug Manufacturers - General names. LLY ranks #4 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
20,266 | $5,099,736 | |
| 2 | JNJ |
Johnson & Johnson
|
19,140 | $4,860,985 | |
| 3 | AZN |
Astrazeneca PLC
|
16,428 | $3,115,077 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
2,212 | $2,653,139 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
42,777 | $2,464,810 | |
| 6 | AMGN |
Amgen Inc
|
2,694 | $975,551 | |
| 7 | NVS |
Novartis AG
|
4,006 | $627,820 | |
| 8 | PFE |
Pfizer Inc
|
23,471 | $565,181 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,653,139 | 2,212 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,895,645 | 2,061 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,073,057 | 1,929 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,493,191 | 1,957 | Shares | Sole | 2025-11-21 | |
| 2025-06-30 | $1,472,532 | 1,889 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $1,554,362 | 1,882 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,503,084 | 1,947 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,800,230 | 2,032 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,866,893 | 2,062 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,604,153 | 2,062 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,508,014 | 2,587 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $996,376 | 1,855 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $869,957 | 1,855 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $637,044 | 1,855 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $678,633 | 1,855 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $593,347 | 1,835 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $562,539 | 1,735 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $496,851 | 1,735 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $479,241 | 1,735 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $400,871 | 1,735 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $398,217 | 1,735 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $324,132 | 1,735 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $229,622 | 1,360 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $208,708 | 1,410 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $231,493 | 1,410 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||